← Leaderboards
Nicole Schmitt
National Institute On Deafness And Other Communication Disorders
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at National Institute On Deafness And Other Communication Disorders
Same institution · by research overlap
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneImmune SystemHuman Cell LineHair CellsFda ApprovedHearing ImpairmentDrug UsageHigh-Frequency Hearing LossAntigen Presentation PathwayDrug StandardAffectCancer TypeHearingHead And Neck Squamous Cell CarcinomaAdvanced DiseaseDoseDeglutitionHead And Neck Cancer PatientCellsCessation Of LifeChemotherapyBaseCisplatinImmunotherapeutic Agent
Grant awards (5)
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma$246,498
ZIA · FY2020 · DC · contact PI
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma$995,719
ZIA · FY2019 · DC · contact PI
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma$1,015,160
ZIA · FY2018 · DC · contact PI
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma$880,830
ZIA · FY2017 · DC · contact PI
Mechanisms and Optimal Combinations of Cisplatin Chemotherapy for Head and Neck Squamous Cell Carcinoma$754,861
ZIA · FY2016 · DC · contact PI